Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar, Ethiopia.
ART
Children
Ethiopia
HIV
Viral load suppression
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
14 May 2019
14 May 2019
Historique:
received:
17
01
2019
accepted:
01
05
2019
entrez:
16
5
2019
pubmed:
16
5
2019
medline:
10
7
2019
Statut:
epublish
Résumé
Human immunodeficiency virus (HIV) infected children represent a very vulnerable population for anti-retroviral therapy (ART) drug resistance. As a global target, 90% of patients receiving ART should have HIV-RNA viral suppression. A threshold of > 1000 RNA copies/ml is used to define non-suppressed viral load. If it is confirmed in the laboratory, adherence should be addressed and should be followed by the switch to second-line ART. Therefore, the aim of this study was to assess the rate of viral load suppression among children tested at the Amhara Public Health Institute (APHI), Bahir Dar. Institutional based cross-sectional study design was conducted from July 01, 2017 to June 30, 2018, in children under the age of 15 years. Socio-demographic, clinical and HIV1RNA viral load data were collected from the excel database. The data were analyzed in SPSS 20.0 statistical software. A total of 1567 children, age ranged from one to 14 years, were tested for HIV viral load. Of which, about 54% were males. Children were treated using nevirapine-based (76.7%), efavirenz-based (21.8%) and protease inhibitor-based (1.5%) anti-retroviral drugs. Non-suppressed HIV viral load was found in 28.3% of the participants. High viral load (> 1000 cp/ml) were found in 24% of the children below the age of five years. Children on nevirapine-based treatment had about two times more non-suppressed viral load (Adjusted odds ratio [AOR]: 1.90; 95%CI: 1.41-2.56; P < 0.001) compared to those who had efavirenz-based treatment. However, adherence (P: 0.204) was not associated with non-suppressed viral load. There was a high rate of non-suppressed HIV viral load among children tested at APHI. Specifically, the odds of having a non-suppressed viral load was higher in NVP based treatment users. Hence, comprehensive management and follow up of children on ART, and testing for resistance as well as viral load could help to reduce the problem in advance.
Sections du résumé
BACKGROUND
BACKGROUND
Human immunodeficiency virus (HIV) infected children represent a very vulnerable population for anti-retroviral therapy (ART) drug resistance. As a global target, 90% of patients receiving ART should have HIV-RNA viral suppression. A threshold of > 1000 RNA copies/ml is used to define non-suppressed viral load. If it is confirmed in the laboratory, adherence should be addressed and should be followed by the switch to second-line ART. Therefore, the aim of this study was to assess the rate of viral load suppression among children tested at the Amhara Public Health Institute (APHI), Bahir Dar.
METHODS
METHODS
Institutional based cross-sectional study design was conducted from July 01, 2017 to June 30, 2018, in children under the age of 15 years. Socio-demographic, clinical and HIV1RNA viral load data were collected from the excel database. The data were analyzed in SPSS 20.0 statistical software.
RESULTS
RESULTS
A total of 1567 children, age ranged from one to 14 years, were tested for HIV viral load. Of which, about 54% were males. Children were treated using nevirapine-based (76.7%), efavirenz-based (21.8%) and protease inhibitor-based (1.5%) anti-retroviral drugs. Non-suppressed HIV viral load was found in 28.3% of the participants. High viral load (> 1000 cp/ml) were found in 24% of the children below the age of five years. Children on nevirapine-based treatment had about two times more non-suppressed viral load (Adjusted odds ratio [AOR]: 1.90; 95%CI: 1.41-2.56; P < 0.001) compared to those who had efavirenz-based treatment. However, adherence (P: 0.204) was not associated with non-suppressed viral load.
CONCLUSIONS
CONCLUSIONS
There was a high rate of non-suppressed HIV viral load among children tested at APHI. Specifically, the odds of having a non-suppressed viral load was higher in NVP based treatment users. Hence, comprehensive management and follow up of children on ART, and testing for resistance as well as viral load could help to reduce the problem in advance.
Identifiants
pubmed: 31088496
doi: 10.1186/s12879-019-4058-4
pii: 10.1186/s12879-019-4058-4
pmc: PMC6518745
doi:
Substances chimiques
Alkynes
0
Anti-Retroviral Agents
0
Benzoxazines
0
Cyclopropanes
0
Nevirapine
99DK7FVK1H
efavirenz
JE6H2O27P8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
419Références
J Infect Dis. 2008 Oct 1;198(7):1075-82
pubmed: 18684096
PLoS One. 2015 Jul 10;10(7):e0131994
pubmed: 26161559
J Virus Erad. 2016 Apr 01;2(2):94-101
pubmed: 27482442
AIDS. 2017 Jan 2;31(1):61-70
pubmed: 27677163
PLoS One. 2017 Jan 31;12(1):e0170893
pubmed: 28141867
BMC Infect Dis. 2017 May 3;17(1):326
pubmed: 28468608
J Int AIDS Soc. 2017 Nov;20 Suppl 7:
pubmed: 29171190
Children (Basel). 2018 Jan 01;5(1):null
pubmed: 29301267
PLoS One. 2018 Jan 11;13(1):e0190659
pubmed: 29324811
BMC Public Health. 2018 Aug 22;18(1):1048
pubmed: 30134880
J Antimicrob Chemother. 2018 Dec 1;73(12):3471-3475
pubmed: 30169653